Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 5,526–5,550 of 7,816 matching trials · page 222 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Modeling the Relationships Between Functional Connectivity and Amyloid Deposition in Alzheimer's Disease NCT04174287 F-18-AV45 Runs in: Taiwan · 1 site |
PHASE2 other |
UNKNOWN | 300 | Chang Gung Memorial Hospital OTHER |
2019-11-22 |
|
A Study to Evaluate the Long-term Safety and Tolerability of Lu AF20513 and the Antibody Response in Patients With Alzheimer's Disease (AD) NCT03668405 Lu AF20513 Runs in: Finland; Sweden · 4 sites |
PHASE1 other |
TERMINATED | 18 | H. Lundbeck A/S INDUSTRY |
2019-11-21 |
|
The Family VOICE Study NCT01804582 Family Navigator consultation Runs in: United States · 1 site |
NA other |
COMPLETED | 350 | University of Maryland, Baltimore OTHER |
2019-11-20 |
|
The Effectiveness of Global Postural Reeducation on Alzheimer Disease Patients NCT03732053 GPR Intervention Research group |
NA other |
COMPLETED | 135 | Universidad Católica San Antonio de Murcia OTHER |
2019-11-19 |
|
Multiple Ascending Dose Study of ALZ-801 NCT04157712 ALZ-801 or matching placebo Runs in: United Kingdom · 1 site |
PHASE1 anti-amyloid-aggregation |
COMPLETED | 48 | Alzheon Inc. INDUSTRY |
2019-11-19 |
|
Remote Ischemic Conditioning of the Human Brain in Dementia Patients NCT04168021 Leg ischemia |
NA other |
UNKNOWN | 90 | Aristotle University Of Thessaloniki OTHER |
2019-11-19 |
|
Effect of Heat Exposure on Cognition in Persons With Tetraplegia NCT02488824 Warm Temperature Runs in: United States · 1 site |
NA other |
COMPLETED | 41 | VA Office of Research and Development OTHER_GOV |
2019-11-18 |
|
24 Months Safety and Efficacy Study of AADvac1 in Patients With Mild Alzheimer's Disease NCT02579252 AADvac1; Placebo Runs in: Austria; Czechia; Germany; Poland; Romania; Slovakia; Slo... · 42 sites |
PHASE2 other |
COMPLETED | 208 | Axon Neuroscience SE INDUSTRY |
2019-11-14 |
|
The Effects of an Extensive Exercise Program on the Progression of Mild Cognitive Impairment NCT02913053 Aerobic exercise; Non-aerobic exercise Runs in: Germany; Ireland; Netherlands · 3 sites |
NA other |
COMPLETED | 183 | Radboud University Medical Center OTHER |
2019-11-14 |
|
A 24-month Phase 1 Pilot Study of AADvac1 in Patients With Non Fluent Primary Progressive Aphasia NCT03174886 AADvac1 40 µg; AADvac1 160 µg Runs in: Germany · 3 sites |
PHASE1 other |
UNKNOWN | 33 | Axon Neuroscience SE INDUSTRY |
2019-11-14 |
|
Effects of an Adaptogenic Extract on Electrical Activity of the Brain in Elderly Subjects With Cognitive Impairment NCT03780621 Andrographis and Withania; Placebo Runs in: Germany · 1 site |
PHASE1 other |
COMPLETED | 16 | EuroPharma, Inc. INDUSTRY |
2019-11-14 |
|
Research on Aging Project in Iceland: Second Stage NCT01322568 Runs in: Iceland · 1 site |
NA other |
COMPLETED | 5,764 | National Institute on Aging (NIA) NIH |
2019-11-12 |
|
Dietary Ketosis: Fatty Acids Activate AMPK Energy Circuits Modulating Global Methylation NCT03319173 Dietary intervention Runs in: United States · 1 site |
NA other |
COMPLETED | 98 | Bristlecone Health, Inc. INDUSTRY |
2019-11-12 |
|
Biomarkers in Neurodegenerative Diseases NCT04055532 Neuraceq Runs in: United States · 1 site |
NA other |
WITHDRAWN | 0 | University of Minnesota OTHER |
2019-11-12 |
|
Online Brain Training Intervention for Over 50s NCT02559700 Brain training programme |
NA other |
COMPLETED | 4,387 | King's College London OTHER |
2019-11-07 |
|
Auditory Stimulation of Slow Wave Sleep and Memory in Mild Cognitive Impairment and Older Adults NCT02608840 Auditory stimulation during sleep; Sham Intervention Runs in: United States · 1 site |
NA other |
COMPLETED | 23 | Northwestern University OTHER |
2019-11-06 |
|
FDG Metabolism in Dementia With Lewy Body (DLB) Patients as Indicated by PET Dynamic Acquisition NCT04154215 PET-CT FDG brain scan |
NA other |
UNKNOWN | 100 | Tel-Aviv Sourasky Medical Center OTHER_GOV |
2019-11-06 |
|
Applying PET/MR for Dementia Applications NCT04154254 PET/MR |
NA other |
UNKNOWN | 50 | Tel-Aviv Sourasky Medical Center OTHER_GOV |
2019-11-06 |
|
PHysical Activity and Exercise Outcomes in Huntington's Disease NCT03344601 physical activity Runs in: Germany; Spain; United States · 6 sites |
NA other |
UNKNOWN | 116 | Cardiff University OTHER |
2019-11-05 |
|
A Study of Staccato Loxapine (ADASUVE®) for Inhalation NCT04148963 Inhaled loxapine; Inhaled placebo |
PHASE3 other |
UNKNOWN | 150 | Lee's Pharmaceutical Limited INDUSTRY |
2019-11-05 |
|
A 4-Week Safety Study of Oral ELND005 in Young Adults With Down Syndrome Without Dementia NCT01791725 ELND005; Placebo Runs in: United States · 3 sites |
PHASE2 anti-amyloid-aggregation |
COMPLETED | 23 | OPKO Health, Inc. INDUSTRY |
2019-11-04 |
|
The Effect of Growth Hormone Releasing Hormone on Cognitive Function in Individuals With Mild Cognitive Impairment NCT02553603 Growth Hormone Releasing Hormone (GHRH); Placebo Growth Hormone Rel... Runs in: United States · 1 site |
PHASE1 other |
COMPLETED | 22 | The University of Texas Medical Branch, Galveston OTHER |
2019-11-04 |
|
Tailored Mediterranean Lifestyle Education in Patients With Mild Cognitive Impairment NCT03265522 "ThinkMed" resource at baseline; Standard Care Control; "ThinkMed" ... Runs in: United Kingdom · 1 site |
NA other |
COMPLETED | 15 | Queen's University, Belfast OTHER |
2019-11-04 |
|
ELND005 in Patients With Mild to Moderate Alzheimer's Disease NCT00568776 Placebo Control; ELND005; ELND005; ELND005 Runs in: Canada; United States · 62 sites |
PHASE2 anti-amyloid-aggregation |
COMPLETED | 353 | OPKO Health, Inc. INDUSTRY |
2019-11-01 |
|
Diet and Aggression: Reducing Aggression Among Chronic Psychiatric Inpatients Through Dietary Supplementation NCT02498106 Orthica Soft Multi Mini and Orthica Fish EPA Mini Runs in: Netherlands · 6 sites |
NA other |
COMPLETED | 176 | Leiden University Medical Center OTHER |
2019-11-01 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial